Skip Navigation

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by WHITTEMORE, A. S.
Right arrow Articles by SILVERS, A.
Right arrow Search for Related Content
PubMed
Right arrow Articles by WHITTEMORE, A. S.
Right arrow Articles by SILVERS, A.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

© 1986 Oxford University Press

other

Pharmacokinetics in Low Dose Extrapolation Using Animal Cancer Data

ALICE S. WHITTEMORE*, STELLA C. GROSSER{dagger} and ABRAHAM SILVERS{ddagger}

*Department of Family, Community and Preventive Medicine, Stanford University School of Medicine {dagger}Department of Statistics, Stanford University Stanford, California 94305 {ddagger}Electric Power Research Institute 3412 Hillview Avenue, Palo Alto, California 94303

Pharmacokinetics in Low Dose Extrapolation Using Animal Cancer Data. WHITTEMORE, A. S., GROSSER, S. C, AND SILVERS, A. (1986). Fundam. Appl. Toxicol. 7, 183-190. Data on rodents exposed to carcinogens indicate that their tumor probabilities are proportional to effective concentrations of parent compound or metabolites at the target tissues. This proportionality suggests that observed nonlinear dose-response curves reflect dose-dependent kinetics between applied dose rate and effective concentrations. Therefore low dose extrapolation procedures that include pharmacokinetic data could improve extrapolation accuracy. To test such procedures, we simulated bioassay and pharmacokinetic "data." Then, ignoring the mechanisms generating the data, we used four extrapolation procedures to estimate tumor probability at a low applied dose rate. Two of the procedures use a pharmacokinetic model and simulated pharmacokinetic data, and two do not. The pharmacokinetic model used for extrapolation was only an approximation to the one used to generate the pharmacokinetic data. The procedures that include pharmacokinetics often performed better and never did much worse than those that ignore them, regardless of the relations used to generate the data, the amount of experimental error in the pharmacokinetic data, and the appropriateness of the pharmacokinetic and extrapolation models used. Moreover they performed substantially better when effective concentration and tumor probability were concave-up functions of applied dose rate.


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?




Disclaimer:
Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.